{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:38:38Z","timestamp":1784115518977,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences and Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jtauto.2021.100092","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T02:08:49Z","timestamp":1614564529000},"page":"100092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals"],"prefix":"10.1016","volume":"4","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2021.100092_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.autrev.2015.11.014","article-title":"Old lines tell new tales: blaschko linear lupus erythematosis","volume":"15","author":"Jin","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2021.100092_bib2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1177\/0961203320959716","article-title":"A\u00a0comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum","volume":"29","author":"Jin","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2021.100092_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamadermatol.2013.9026","article-title":"Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus","volume":"150","author":"Wieczorek","year":"2014","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.jtauto.2021.100092_bib4","article-title":"Higher specificity of the new EULAR\/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus","author":"Stec-Polak","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100092_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/1744666X.2020.1805316","article-title":"New insights into the progression from cutaneous lupus to systemic lupus erythematosus","volume":"16","author":"Zhou","year":"2020","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2021.100092_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MOP.0000000000000383","article-title":"Immunogenetics of cutaneous lupus erythematosus","volume":"28","author":"Hersh","year":"2016","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.jtauto.2021.100092_bib7","article-title":"Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes","volume":"8","author":"Berthier","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.jtauto.2021.100092_bib8","doi-asserted-by":"crossref","first-page":"5049245","DOI":"10.1155\/2019\/5049245","article-title":"MicroRNA expression in cutaneous lupus: a new window to understand its pathogenesis","volume":"2019","author":"M\u00e9ndez-Flores","year":"2019","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.jtauto.2021.100092_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000770","article-title":"Immunopathogenesis of skin injury in systemic lupus erythematosus","volume":"332","author":"Hile","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100092_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/BOR.0000000000000739","article-title":"Cutaneous and systemic connections in lupus","volume":"32","author":"Maz","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100092_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13075-019-2034-4","article-title":"Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin","volume":"21","author":"Lambers","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2021.100092_bib12","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","article-title":"IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus","volume":"75","author":"Zhao","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100092_bib13","doi-asserted-by":"crossref","first-page":"108612","DOI":"10.1016\/j.clim.2020.108612","article-title":"A\u00a0simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus","volume":"221","author":"Zhang","year":"2020","journal-title":"Clinical immunology (Orlando, Fla"},{"key":"10.1016\/j.jtauto.2021.100092_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s12885-018-4529-9","article-title":"IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met\/Src signaling pathway","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Canc."},{"key":"10.1016\/j.jtauto.2021.100092_bib15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/jir.2011.0071","article-title":"Interferon alpha as a primary pathogenic factor in human lupus","volume":"31","author":"Niewold","year":"2011","journal-title":"J.\u00a0Interferon Cytokine Res. : the official journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/j.jtauto.2021.100092_bib16","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","article-title":"IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus","volume":"75","author":"Zhao","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100092_bib17","doi-asserted-by":"crossref","first-page":"107028","DOI":"10.1016\/j.intimp.2020.107028","article-title":"Recent advances in understanding pathogenesis and therapeutic strategies of Systemic Lupus Erythematosus","volume":"89","author":"Luo","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.jtauto.2021.100092_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.07.007","article-title":"A\u00a0comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus","volume":"93","author":"Li","year":"2018","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100092_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2133.2012.10825.x","article-title":"The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score","volume":"166","author":"Braunstein","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2021.100092_bib20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1136\/annrheumdis-2019-215571","article-title":"Ultrasensitive serum interferon-\u03b1 quantification during SLE remission identifies patients at risk for relapse","volume":"78","author":"Mathian","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100092_bib21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/jdv.13769","article-title":"Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus","volume":"30","author":"Patsinakidis","year":"2016","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol. : JEADV"},{"key":"10.1016\/j.jtauto.2021.100092_bib22","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.12688\/f1000research.21584.1","article-title":"DNA methylation changes in biomarker loci occur early in cancer progression","volume":"8","author":"Vrba","year":"2019","journal-title":"F1000Research"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:35:36Z","timestamp":1762904136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909021000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":22,"alternative-id":["S2589909021000125"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100092","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100092"}}